31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Yesterday, Governor Gavin Newsom signed California Assembly Bill 5 (“AB5”), controversial legislat...
Read More >
The United States District Court of Oregon (“Court”) addressed in an April 14th Opinion an action ...
Read More >
On March 26, 2020, Governor Cuomo directed modifications to the guidance on his Executive Order 202....
Read More >
On September 24, 2019, the U.S. Department of Labor (DOL) announced its final rule updating the earn...
Read More >
In 2019, as in previous years, most of the new labor and employment law legislation was enacted at t...
Read More >
Both the French and German authorities are particularly active in merger control at the member state...
Read More >